Detection of malignant primary hepatic neoplasms with gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted hepatocyte phase MR imaging: results of off-site blinded review in a phase-II multicenter trial.

OBJECTIVE: To investigate the efficacy of gadobenate dimeglumine (Gd-BOPTA) enhanced MR imaging for the detection of liver lesions in patients with primary malignant hepatic neoplasms. MATERIALS AND METHODS: Thirty-one patients with histologically proven primary malignancy of the liver were evaluated before and after administration of Gd-BOPTA at dose 0.05 or 0.10 mmol/kg. T1-weighted spin echo (T1W-SE) and gradient echo (T1W-GRE) images were evaluated for lesion number, location, size and confidence by three off-site independent reviewers and the findings were compared to reference standard imaging (intraoperative ultrasound, computed tomography during arterial portography or lipiodol computed tomography). Results were analyzed for significance using a two-sided McNemar's test. RESULTS: More lesions were identified on Gd-BOPTA enhanced images than on unenhanced images and there was no significant difference in lesion detection between either concentration. The largest benefit was in detection of lesions under 1 cm in size (7 to 21, 9 to 15, 16 to 18 for reviewers A, B, C respectively). In 68% of the patients with more than one lesion, Gd-BOPTA increased the number of lesions detected. CONCLUSION: Liver MR imaging after Gd-BOPTA increases the detection of liver lesions in patients with primary malignant hepatic neoplasm.

Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT.

PURPOSE: To determine whether computed tomographic (CT) scans and attenuation measurements on contrast material-enhanced and nonenhanced CT scans could be used to characterize adrenal masses, in particular, to characterize these lesions by using adrenal washout characteristics at contrast-enhanced CT. MATERIALS AND METHODS: Eighty-six patients (49 men, 37 women; age range, 29-86 years; mean age, 72 years) with 101 adrenal lesions depicted at contrast-enhanced CT underwent delayed (mean, 9 minutes) enhanced scanning. Seventy-eight patients also underwent nonenhanced CT. Mean diameter of the benign lesions was 2.1 cm (range, 1.0-4.2 cm); mean diameter of the malignant lesions was 2.3 cm (range, 1.0-4.1 cm). Region-of-interest measurements were obtained at nonenhanced, dynamic enhanced, and delayed enhanced CT and were used to calculate a relative percentage washout as follows: 1 - (Hounsfield unit measurement on delayed image / Hounsfield unit measurement on dynamic image) x 100%. RESULTS: Ninety-nine of 101 lesions were correctly characterized as benign or malignant with a relative percentage washout threshold of 50% on delayed scans; benign lesions demonstrated more than 50% washout; and malignant lesions, less than 50% washout. Two benign lesions demonstrating less than 50% washout were characterized as benign by using conventional CT. CONCLUSION: Calculation of relative percentage washout on dynamic and delayed enhanced CT scans may lead to a highly specific test for adrenal lesion characterization, reduce the need for, and possibly obviate, follow-up imaging or biopsy.

Gadopentetate dimeglumine: a possible alternative contrast agent for CT angiography of the aorta.

We report the use of a gadolinium chelate for limited CT angiography of the aorta in a patient in whom iodinated contrast agent was contraindicated and who had undergone nondiagnostic MRI.

Quantitative blood flow measurements with cine phase-contrast MR imaging of subjects at rest and after exercise to assess peripheral vascular disease.

OBJECTIVE: The purpose of this study was to determine whether cine phase-contrast MR volume flow measurements can identify patients with peripheral vascular disease. SUBJECTS AND METHODS: We performed MR measurements of volume blood flow in the popliteal artery of subjects at rest and after 5 min of plantar flexion exercise in 10 volunteers (mean age, 28 years old), in five patients suspected of having peripheral vascular disease (mean age, 58 years old), and in five other volunteers of a similar age (mean age, 57 years old). RESULTS: Volume blood flow at rest was similar in volunteers and in patients. Four patients who had abnormal ankle-brachial indexes had lower flow increases after exercise (2.6-fold) compared with the five older normal volunteers (4.8-fold; p < .03, t test). These flow increases correlated well with ankle-brachial indexes: r = .97. The four patients with abnormal ankle-brachial indexes had monophasic resting waveforms, whereas all other subjects had triphasic waveforms. CONCLUSION: MR volume blood flow measurement may aid in evaluating peripheral vascular disease. Studies of larger patient groups will be necessary.

Validation of volume flow measurements with cine phase-contrast MR imaging for peripheral arterial waveforms.

A flow phantom was used to study MR volume flow measurements for monophasic and triphasic waveforms over the flow range expected in peripheral arteries at rest and with exercise (2-24 mL/sec, n = 50). The improvement in accuracy with phase-correction image processing to eliminate errors caused by eddy currents was measured. Volume flow estimates with Doppler sonography were also measured. MR volume flow measurements correlated with volume collection with r = .996 and mean error = 4.6%. Phase-correction processing decreased mean error from 12.6% to 4.6% (P < .001, paired t-test). Doppler sonography had a higher mean error of 10.3% (P < .001, unpaired t-test). Cine phase-contrast MR imaging provides accurate estimates of volume blood flow for waveforms and flow ranges expected in peripheral arteries.